CTN(SZ:300430) Zheng Quan Ri Bao Wang·2025-06-16 13:15Group 1: Industry Development - The first invasive brain-computer interface (BCI) clinical trial in China has been successfully conducted, marking a significant breakthrough in the technology, making China the second country globally to enter this phase after the United States [1] - The BCI technology is rapidly advancing, transitioning from laboratory research to clinical applications, with various policies being implemented to support its development [2][3] - The market size for China's BCI industry is projected to reach 3.2 billion yuan in 2024, with an annual growth rate of 18.8%, expected to increase to 5.5 billion yuan by 2027 [3] Group 2: Company Initiatives - Several listed companies are increasing their R&D investments in BCI technology, exploring applications in healthcare and entertainment [4] - Beijing Chengyitong Technology Group has established a dual-track strategy focusing on both invasive and non-invasive BCI technologies, aiming to enhance existing rehabilitation devices and conduct foundational research [4] - Henan Xiangyu Medical Equipment Co., Ltd. has developed a series of wireless EEG acquisition systems for various rehabilitation scenarios, indicating a proactive approach to integrating BCI technology into medical applications [4]